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Abstract
Background: The importance of poultry as a global source of protein underpins the chicken genome and
associated SNP data as key tools in selecting and breeding healthy robust birds with improved disease resistance.
SNPs affecting host peptides involved in the innate defences tend to be rare, but three non-synonymous SNPs in
the avian β-defensin (AvBD1) gene encoding the variant peptides NYH, SSY and NYY were identified that
segregated specifically to three lines of commercial broiler chickens Line X (LX), Line Y(LY) and Line Z. The impacts
of such amino acid changes on peptide antimicrobial properties were analysed in vitro and described in relation to
the caecal microbiota and gut health of LX and LY birds.
Results: Time-kill and radial immune diffusion assays indicated all three peptides to have antimicrobial properties
against gram negative and positive bacteria with a hierarchy of NYH > SSY > NYY. Calcein leakage assays supported
AvBD1 NYH as the most potent membrane permeabilising agent although no significant differences in secondary
structure were identified to explain this. However, distinct claw regions, identified by 3D modelling and proposed
to play a key role in microbial membrane attachment, and permeation, were more distinct in the NYH model. In
vivo AvBD1 synthesis was detected in the bird gut epithelia. Analyses of the caecal gut microbiota of young day 4
birds suggested trends in Lactobacilli sp. colonisation at days 4 (9% LX vs × 30% LY) and 28 (20% LX vs 12% LY)
respectively, but these were not statistically significant (P > 0.05).
Conclusion: Amino acid changes altering the killing capacity of the AvBD1 peptide were associated with two
different bird lines, but such changes did not impact significantly on caecal gut microbiota.
Keywords: Avian β-defensin 1, Gene SNPs, Antimicrobial activity, Membrane permeabilisation, Gut bacteria
Background
The defensins comprise groups of innate effectors syn-
thesised by epithelia and antigen presenting cells that
function as a first line defence mechanism to protect the
host from infection. These small molecular weight mole-
cules, less than 50 aa in length and 2 to 6 kDa in size, are
noted for their broad-spectrum anti-microbial properties,
which are facilitated through their small size, cationic charge
and preponderance of hydrophobic amino acids [1, 2]. In
addition to their killing activities mammalian defensins
exhibit an array of immuno-protective functions that include
wound healing, chemotaxis and mast cell degranulation,
while roles in development and reproduction have also been
reported [3]. While mammals are characterised by three
defensin families namely α, β, and θ, with the latter being
confined to macaques and baboons, birds synthesise only
one family, the β-defensins. Evolutionarily these molecules
represent the oldest of the defensin families, are found in
most classes of vertebrates and typified by the C1-C5, C2-
C4 and C3-C6 disulphide bridging pattern of the six
conserved cysteines. In the chicken genome the family
includes a cluster of 14 distinct β-defensin (AvBD)
genes located within 86 kb of chromosome 3 that has
evolved, presumably, through gene duplication [4, 5].
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As well as roles in the host innate defences, which pivot-
ally involve protecting the epithelia from microbial assault,
the defensins also function in regulating the endogenous
gut microflora [6]. Thus any mutations that affect peptide
expression and/or structure, and hence microbial killing
properties, can potentially lead to an altered innate im-
munity and/or microbiota, resulting in an increased sus-
ceptibility of the host to disease. As a consequence,
natural allelic variations or SNPs within the defensin loci
are uncommon and are generally identified through the
increased sensitivity of individuals to diseases, particularly
those involving epithelial-microbial interactions [7].
Poultry, particularly chicken, are a major source of
protein worldwide and the commercial, and nutritional
value of the meat has for decades, underpinned research
into optimising bird production. Recent research has
also focussed on rearing ‘robust’ healthy birds that not
only show optimal feed to gain ratios, but can also resist
infectious and/or zoonotic diseases [8]. Genomic and
SNP data has therefore become of increasing importance
to breeders, and SNPs identified within the defensin
genes have already been proposed as molecular markers
to facilitate the selection of commercial poultry resistant
to enteric pathogens [9]. Yet, while many SNPs associate
with the required trait in multiple rearing environments
a number have been identified that are particularly sensi-
tive to the external conditions. For example, the TGFβ3
Msp1 SNP associates with increased mortality in high,
but not low hygiene environments. These observations
suggest that interactions between genetic and environ-
mental factors are not only important, but multifaceted,
and for breeding purposes direct the selection of SNPs
less sensitive to environmental changes [10].
Non-synonomous amino acid changes that affect pep-
tide functionality can impact on an organism’s pheno-
type although for molecules functioning in innate
immunity, genetic changes that direct such mutations
tend to be infrequent. However, in two domestic chicken
breeds, White Leghorn and Cornish, the chicken NK-
lysin gene, encoding an innate defence molecule with
microbiocidal and cytolytic activities, has been shown to
carry coding sequence variation [11]. The polymorphism
involves a single nonsynonymous SNP at nucleotide 271
that results in an Asn (N) to Asp (D) amino acid substi-
tution and peptides synthesised to model this change in-
dicate the N29 N peptide to exhibit greater antibacterial
activity compared to the N29D variant. Within an array
of inbred and heritage chicken breeds the A SNP encod-
ing an asparagine (N) dominates, suggesting that positive
selection of this amino acid has been driven by the su-
perior killing properties of the peptide in response to the
global microbial challenge [12].
To date there are limited reports describing natural al-
lelic variation of the AvBDs and the consequences
thereof. In this study analyses of SNP panels from differ-
ent commercial elite broiler chicken lines identified
three non-synonymous SNPs in the AvBD1 mature pep-
tide coding region [13]. The SNPs resulted in amino acid
changes at positions 10, 20 and 32 with the variant pep-
tides identified as NYH, SSY and S/NYY. The ‘NYH’
peptide represented the major AvBD1 form synthesized
in Line X (LX) birds, ‘SSY’ typified AvBD1 in Line Y (LY)
birds, while ‘N/SYY’ represented the peptides synthe-
sised by Line Z (LZ). To explore the impact of the
AvBD1 SNPs this study, utilising synthetic peptides
modelling AvBD1 NYH, SSY and NYY, examined and
compared the effects of the amino acid changes on the
antimicrobial properties of the peptides. These data were
discussed in relation to the gut microbiotae of LX and
LY birds.
Methods
Bacterial growth
Bacteria used in the study were isolated from the gastro-
intestinal tracts of birds reared on commercial farms.
The Escherichia coli, Barnsiella viscericola, Bacteroides
dorei and Lactobacillus johnsonii strains were isolated
post mortem from a Ross 308 broiler chicken. The En-
terococcus faecalis isolate was similarly isolated, but from
a different bird. Blood agar was used for the growth of E.
coli and E. faecalis; brain heart infusion (BHI) broth and
agar were used for the growth of B. viscericola. Rogosa
and Sharpe (MRS) broth and agar were used for cultur-
ing L. johnsonni. B. dorei strains were grown in Tryptone
Yeast Glucose (TYG) broth containing tryptone peptone
(1 g), bacto yeast extract (0.5 g), glucose (0.2 g), cysteine
(free base) (0.05 g), 1 M KPO4 pH 7.2 (10 ml), Vitamin
K solution, 1 mg/ml (1 ml), TYG salts (4 ml), 0.8% CaCl2
(0.1 ml), FeSO4, 0.4 mg/ml (0.1 ml), resazurin, 0.25 mg/
ml (0.4 ml) and H2O (85 ml). Prior to culturing, haem-
atin (w/v %) was added to a final concentration of 0.1%
w/v. E. coli and E. faecalis were grown aerobically while
B. dorei, L. johnsonii and B. viscericola were cultivated
on plates contained in an anaerobic jar (Anaerocult®
system, VWR International, U.K.).
Antimicrobial assays (AMA)
Time-kill assay
A single colony of either E. coli or E. faecalis was grown
overnight in 5 ml broth at 37 °C with gentle shaking.
10 ml LB containing 100 mM glucose was inoculated
with 200 μl of the overnight culture and the bacteria
grown to mid-log (OD600nm 0.3–0.6). Working bacterial
stocks were prepared by diluting the culture 1:1000 with
0.1 M phosphate buffered saline (PBS). The colony
counting assay [14] was modified to use 96-well microti-
tre plates and 2 h incubation time periods. The bacterial
growth inhibited by each peptide sample was presented
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relative to the PBS control, which was assigned a growth
value of 100%. Each assay was repeated on at least three
separate occasions with minimum of two replicates for
each peptide/control sample.
Radial diffusion assay
Assays were performed as described for human β-
defensin-1 [15]. Briefly bacteria were grown to mid-log
from an overnight culture and pelleted by centrifugation
(1000 g) for 10 min. The media was removed, the pellet
was washed with cold 10 mM phosphate buffer, re-
centrifuged, re-suspended to an OD600nm of 0.1 nm
(against a buffer control) and kept on ice until required.
150 μl of diluted bacterial suspension (OD600nm 0.1 nm)
was added to a 10 ml aliquot of liquid ‘underlay’ gel at
45 °C, gently mixed, poured into a petri-dish and
allowed to set. Wells (3 mm) were punched into the gel
and either peptide or PBS buffer added. After 3 h, 5 ml
of melted overlay was added to each plate, allowed to
dry and the plates incubated overnight. Zones of bacter-
ial inhibition were photographed and measured using
ImageJ software (imagej.nih.gov/ij/, National Institutes
of Health, Maryland, U.S.A.).
For the assessment of peptide activities against anaer-
obic bacteria (B. dorei, B. viscericola and L. johnsonii)
the underlay and overlay aliquots also contained a redu-
cing agent, dithiothreitol (DTT) (1 mM), and a redox-
indicator, resazurine (1 μg/ml). Anaerobic bacteria were
cultured under anaerobic conditions using the Anaero-
cult® system (VWR International, U.K.).
Synthetic (s) AVBD1 peptides
Three AvBD1 variants termed ‘NYH’, ‘SSY’ and ‘NYY’
based on their primary sequence were synthesised by
PeptideSynthetics (Hampshire, UK) with >95% purity.
Lyophilised peptide was stored at −20 °C and a working
stock of 1 mg/ml prepared by dissolving 1 mg peptide in
20 μl of 10% acetic acid and the volume increased to
1 ml using Milli-Q water.
CD spectroscopy
CD spectroscopy was carried out on a Jasco-810 CD spec-
tropolarimeter. For far-UV measurements (250–185 nm)
at room temperature 0.2 cm Hellma stoppered cuvettes
were used, the bandwidth was set to 0.2 nm, data pitch
0.5 nm and scanning speed 100 nm/min. Secondary struc-
tures were predicted using Dichroweb software (http://
dichroweb.cryst.bbk.ac.uk/html/home.shtml). The CD
spectra data were inputted and outputted as text files and
delta epsilon units from 190 to 240 nm using K2D soft-
ware [16].
Calcein leakage assay
Lipid stock solution (50 mg/ml) was prepared by mixing
soya bean, type II S Phospholipid powder, L-α- Phos-
phatidylcholine (Sigma) with hexane (BHD, VWR, UK)
and few drops of ethanol, and stored at −20 °C. For ex-
periments, 2 ml (100 mg) of the lipid solution were dried
to a film in a round bottom flask. Calcein solution
(20 mM) was prepared by dissolving calcein (Sigma) in
100 mM sodium phosphate buffer and filtering through
a 0.2 μm membrane. To create calcein-trapped multila-
melar (MLV) vesicles, 2 ml of the calcein solution was
added into the lipid film and this shaken with clean glass
beds (2.5–3.5 mm) for 20 min at room temperature.
Unilamellar vesicles (ULV) were prepared by passing the
MLV through a miniextruder (Avanti) with 100 nm poly-
carbonated membrane at least 11 times. Untrapped
(free) calcein molecules were removed using a PD-10
desalting column (GE Healthcare). Calcein leakage from
the ULV liposomes was monitored using a fluorescent
spectrophotometer (Varian) and Cary Eclipse software,
Excitation (493 nm) and emission (505-600 nm).
TritonX-100 (1% final concentration) was used as a
100% leakage positive control. Leakage was calculated
using the equation: Leakage % = (Fp-F0)/ (Ft-F0) *100%,
when Fp is the measurement of fluorescent leakage by
the peptides, Ft is the complete leakage by TritonX and
F0 is intact vesicles before adding peptide or TritonX.
Modelling
The AvBD1 peptide structures were modelled using
Raptor X online software (http://raptorx.uchicago.edu/)
[17]. The three dimensional structure prediction used the
Penguin AvBD 103b (Spheniscin-2) structure, solved pre-
viously using two dimensional NMR, as its template [18].
SNP genotyping
SNP genotyping data related to ten commercial broiler
breeding lines, including LX, LY and LZ, and a mini-
mum of 200 birds per line [19]. Genotyping and geno-
type scoring was performed by Illumina using a 12 K
SNP array panel. Pooled genomic DNA was also directly
sequenced (GENEVISION, Newcastle upon Tyne) and
SNP allele frequency determined [20]. Each pool con-
tained DNA from 20 birds; six pools were sequenced for
LX and LY, and five pools for LZ.
Birds & Rearing Environment
Two independent trials were completed each involving
thirty newly hatched birds from the two Aviagen broiler
chicken genotypes LX and LY. In trial 1, 15 LX and 15
LY birds, were assigned to pens each containing of 5
birds within a ‘sib-test’ facility [21]. All birds were fed
standard feed ration (maize crumble) and at 4, 21 and
28 days the gut health of each bird was assessed and
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scored for redness, watery digesta and gut tone. Each
gut was assigned a score of 0 (normal), 1 (some abnor-
malities) or 2 (very abnormal) with poorest guts scoring
6 across all three gut-health traits. This procedure was
repeated for trial 2.
Gut microbiome
DNA extraction of pooled caecal digesta samples (max-
imum of 5 birds/pool) was performed using the DNA-
zol™ kit (Life Technologies Ltd., Paisley, UK). DNA
pellets were re-suspended in 200 μl of TE elution buffer
(Qiagen, UK) with concentration and purity assessed by
Nanodrop. Bacterial DNA was analysed by 454-pyro se-
quencing (Roche, Indianapolis, U.S.A) targeting the V4-
V5 region of the bacterial 16S ribosomal gene as a
service by the Animal Health and Veterinary Laborator-
ies Agency (AHVL), Weybridge, U.K. Sequencing
returned over 10,000 reads per sample, each read was
400–500 bp in length and any poor quality reads were
discarded. Methods used for prediction of identities
from the sequencing data were automated and involved
using BLASTn against Ribosomal databases [22]. Data
were formatted by AHVL to show percentage abundance
of each identified genus in relation to the overall
microbiome.
Immunohistochemistry
A rabbit polyclonal antibody to AvBD1 was produced by
Cambridge Research Biochemicals (Cleveland, U.K.)
using the unique peptide antigen, GRKSDSFRKNGFC-
amide and used in the IHC analyses. Avian tissue was
harvested and fixed in 4% buffered formalin and subse-
quently stored in 70% ethanol before being processed
into paraffin blocks. Tissue was sectioned at a thickness
of 4 μm onto SuperFrost Plus slides (Fisher Scientific,
Loughborough, U.K.) and allowed to dry for 24 to 48 h.
For staining, slides were de-waxed in xylene, rehydrated
through graded alcohols to water and subjected to a
hydrogen peroxide block (1.5% in water) for 10 min. Fol-
lowing antigen retrieval by pressure cooking with EDTA
(pH 8.0), staining was carried out using the Vectastain
Elite ABC peroxidase kit (rabbit) (Vector Laboratories,
Peterborough, U.K.) as per manufacturers’ instructions.
Antibody was used at 1:250 dilution in TBS (pH 7.6) for
1 h at room temperature. The reaction was developed using
the peroxidase chromogen DAB (3,3-diaminobenzedine tet-
rahydrochloride) as per manufacturer’s instructions and the
nuclei counterstained using Mayer’s Haematoxylin and
Scot’s tapwater substitute.
Statistical analyses
Statistical analyses were performed using the Prism 5
Software package (GraphPad Software Inc., La Jolla,
California, USA). For analyses of data involving more
than two groups a two–way analysis of variance followed
by Tukey’s multiple comparison or Bonferroni post-
tests, as appropriate, was used. Significance of micro-
biota data between LX and LY groups at each time-point
was determined by unpaired two-tailed Student’s t test.
The significance level was set at 5% (P < 0.05).
Results
AvBD1 gene SNP identification
Two methods were used to identify amino acid substitu-
tions within AvBD1, an Illumina 12 K SNP panel array,
which generated Table 1 and direct sequencing that gen-
erated Table 2. Examination of the AvBD locus on
chromosome 3 identified 15 SNPs that were exhibited
by three bird lines LX, LY and LZ shown by linkage dis-
equilibrium to be phylogenetically distinct [19]. Of the
SNPs identified, 13 were located in the intronic and/or
non-coding sequence of the AvBD genes 1 to 10 (Table
1), while the SNPs identified within the exon 1 region of
AvBD3 and the exon 2 gene sequence of AvBD1 (Rs
15,457,749) were both predicted to encode non-
synonomous amino acid changes. Direct sequencing of
pooled DNA samples from these bird lines confirmed
the frequency of the AvBD1 Rs 15,457,749 SNP Illumina
data (Table 2), and identified two additional SNPs in the
Table 1 AvBD SNPs. AvBD SNPs identified in commercial broiler
chicken lines LX, LY and LZ using 12 K SNP panel array. Pooled
genomic DNAs from 120 LX and LY birds, and up to 100 LZ
birds were analysed for AvBD1 Exon 2 coding SNPs. SNP
AvBD1a (A > G) at c.104, is defined as position of SNP where 1
is A of ATG start codon of AvBD1 cDNA sequence; Rs15457749
(A > C) at c.134 and Rs15457747 (C > T) at c.169. A > G
represents nucleotide substitution in sense DNA strand.
Data presented as mean frequency ± SEM
AvBD Gene SNP Code Location LX LY LZ
Frequency
1 Rs15457749 G/T Exon 2 0.87 0.02 0.55
1 Rs15457745 C/T Intron 0.87 0.22 0.72
3 SNPAvBD3a C/T Exon 1 0.87 0.23 0.89
4 Rs16341536 T/C 5’UTR 0.99 1 0.58
6 Rs13526000 T/G Intron 0.49 0 0.28
6 Rs16341514 G/T Intron 0.17 1 0.28
8 Rs15457650 G/T Intron 0.08 0 0.26
8 Rs15457653 T/C Intron 0.58 0.21 0.72
8 SNPAvBD8a C/T Intron 1 1 0.82
9 Rs3137928 T/C 3’UTR 0.08 0.14 0.61
9 Rs14411786 C/T Intron 0.97 0.86 0.65
9 SNPAvBD9a T/C Intron 0.99 0.86 0.36
10 Rs15457607 T/C Intron 0.88 0.98 0.45
10 Rs14411785 T/C 5’UTR 0.94 0.86 0.65
10 SNPAvBD10a T/C Intron 0.85 0.98 0.44
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AvBD1 mature peptide coding region at positions c.169
(Rs 15,457,747) and c.104 (SNPAvBD1a). All three
AvBD1 SNPs were located in exon 2 and encoded non-
synonymous amino acid changes (Table 1). Analyses of
the primary amino acid sequences of the AvBD1 variants
showed that they differed in amino acids 10, 20 and 32
with NYH, SSY and S/NYY variants composed of aspara-
gine (N)10, tyrosine (Y)20 and histidine(H)32; S10, S20
and Y32 and S/N10, Y20 and Y32, respectively. Hence,
the sole variant in LX has an amino acid sequence
N(10)-Y(20)-H(32), denoted NYH; the main variant in
Line LY has sequence SSY and the main variant in Line
Z has sequence N/SYY.
Anti-microbial activities of sAvBD1 ‘NYH’, ‘SSY’ and ‘NYY’
peptides
The amino acid changes underpinning the NYH, NYY
and SSY AvBD1 variants did not significantly affect ei-
ther the molecular weights (4645, 4671, 4568 Da) or net
charges of the variants (+7.8, +7.7, +7.7). To investigate
the potential effects of the amino acid changes on func-
tionality the antimicrobial properties of synthetic NYH,
SSY and NYY AvBD1 peptides were compared using
bacterial strains isolated from the gastrointestinal tracts
of commercially raised birds.
The radial diffusion assay data, although qualitative,
suggested a hierarchy of NYH > SSY > NYY against both
Gram negative and positive bacteria isolated from the
chicken GI tract (Fig. 1a, c). At 1. 2.5 and 5 μg/ml the
time-kill assay data did not discriminate between the
variants. However, at 10 μg/ml the ‘NYH’ form of the
peptide, synthesized by the Line X birds, was associated
with only 5% E.coli survival (95% killing activity), which
compared to 34.5% and 23% survival (65.5% and 77%
killing) respectively for the SSY and NYY peptides. At 25
μg/ml bacterial survival was <10% for all three peptides.
The NYH > SSY > NYY killing pattern was observed for
Enterococcus faecalis although the bacteria were more
sensitive to lower concentrations of the NYH peptide
with 40% killing at 5μg/ml compared to 17 and 24% for
SSY and NYY (Fig. 1b, d). Additionally at 25μg/ml bac-
terial survival was still evident for the SSY and NYY pep-
tides (18% and 32% respectively).
Radial diffusion assays performed under anaerobic con-
ditions and used to explore the activities of the peptides
against Lactobacillus johnsonii and Barnsiella viscericola
(Fig. 2a,b) again supported the NYH > SSY > NYY anti-
microbial hierarchy although the Bacteroides dorei data
were less clear (Fig. 2c).
Effects of AvBD1 on membrane Permeabilisation
To further investigate the NYH > SSY > NYY antimicro-
bial hierarchy, the abilities of the three AvBD1 peptides
to permeabilise bacterial membranes were explored
using artificial liposomes loaded with calcein dye. The
mean leakage assay data showed that sAvBD1 NYH, SSY
and NYY at concentrations of 1.5 μg/ml (0.3 μM) in-
duced 47.9%, 26.5% and 21.7% calcein leakage respect-
ively, and within 6 s of addition (Fig. 3A). In each case
leakage plateaued within three minutes at 58.9%, 38.6%
and 32.7%, which compared to 70.5% for melittin,
known for its permeabilisation properties [23]. Increas-
ing AvBD1 to 2.5 μg/ml (0.5 μM) induced 78.0%, 61.4%
and 47.5% leakage within 6 s, with leakage stabilised at
3 min (Fig3B&C) and recorded as 100% (NYH), 88.0%
(SSY) and 74.6% (NYY) respectively. These data sug-
gested that the sAvBD1 NYH peptide was the most po-
tent membrane permeabilising agent and supported a
peptide hierarchy of NYH > SSY > NYY.
Table 2 AVBD1 SNP frequencies within pooled genomic DNA samples. Encoded amino acids are presented using the one letter
code system with N:Asparagine; S:Serine; Y:Tyrosine; H:Histidine. Only the most common amino acid combinations of the AvBD1
peptides synthesised by LX, LY and LZ birds are presented
AvBD1 SNP Bird Line T base % G base % C Base % ±SEM Amino acid
AvBD1a
c.104 (A > G)
X (120) 100 0 0 N (AAT)
Y (120) 10.7 89.3 6.6 S (AGT)
Z (80) 48.8 51.2 1.2 N/S
Rs15457749
c.134 (A > C)
X (120) 100 0 0 Y (TAC)
Y (120) 4.3 95.7 4.3 S (TCC)
Z (100) 38.9 61.1 1.1 Y
Rs15457747
c.169 (C > T)
X (120) 13.8 86.2 3.2 H (CAC)
Y (120) 89.7 10.3 7.4 Y (TAC)
Z (100) 61.4 38.6 1.6 Y
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AvBD1 peptide secondary structure
Previous studies, focussed on ostrich defensins and NK-
lysin, linked membrane leakage properties and bacterial
killing to peptide charge [11, 24]. This could not be vali-
dated for the three AvBD1 peptides as their net charges
were comparable. UV circular dichroism was used to ex-
plore whether the AMA and permeabilisation data could
be explained by changes in the secondary structure con-
formations of the peptides following contact with the
bacterial lipid membranes. The CD spectra of the linear
NYH, NYY and SSY peptides in aqueous solution
(10 mM phosphate buffer solution) predicted mostly un-
ordered structure, but with some α-helix and β-sheet
content (Fig. 4). Following exposure of the peptides to
1% SDS to model the anionic environment of the bacter-
ial membrane, an increase in α-helix content was ob-
served for all three peptides, although no significant
differences in secondary structure were identified.
a b c
Fig. 2 Antimicrobial Activities of the AvBD1 Variants (anaerobic environment): Radial diffusion data showing inhibitory effects of AvBD1 variant
peptides against (a) Lactobacillus johnsonii (b) Barnsiella viscericola and (c) Bacteroides dorei
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Fig. 1 Antimicrobial Activities of the AvBD1 Variants (aerobic environment): Radial diffusion data showing inhibitory effects of AvBD1 variants
against a) E.coli and c) E.faecalis. Time-kill assay data showing bacterial growth following 2 h incubation of b) E.coli and d) E.faecalis with AvBD1
variant peptides (Data presented as mean ± SEM; N = 3 experiments and minimum of 6 replicates)
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AVBD1 modelling
To further investigate reasons for the differences in anti-
microbial activities in silico modelling of the three vari-
ant sequences was used. The models predicted folded
structures all containing comparable backbones display-
ing significant β-sheet content linked to three di-
sulphide bonds and an N-terminal α-helix. All models
indicated externalisation and clustering of positively
charged and hydrophobic side chains including those of
four phenylalanines, F7, F12, F15 and F31. The 3D
model of AvBD1 NYH appeared unique with the side
chains of W39/K9 and R30/2 associated with ‘claw-like’
structures; the former structure also linked to the posi-
tive charges of lysine K36 and arginine R37, and the lat-
ter to lysines K27 and K3, and histidine H32 (Fig. 5A/B).
Although the SSY model predicted a similar configur-
ation to NYH, subtle changes were evident. The replace-
ment of Y20 with a negatively charged serine residue
disrupted the hydrophobicity of the Y20/W39 cluster,
and this was associated with the lessening of the claw-
like structure (Fig. 5C/D). The model relating to the
NYY variant was characterised by the attenuation of the
two claw-like structures, presumably a direct conse-
quence of the N10, Y20 and Y32 side chains impacting
on peptide folding (Fig. 5E/F).
Bird gut Microbiotae
Caecal gut epithelial synthesis of AvBD1 was confirmed
by IHC (Fig. 6A). Analyses of the microbiotae residing in
the caecae of LX and LY birds, at ages 4, 21 and 28 days
are presented in Fig. 6B & C. These data relate to 60
birds sampled from two independent trials involving two
different hatches. Of the genera identified Lactobacilli
sp. were predominant in the caeca of both lines, LX and
LY, at the three sampled time points. While these
a
b
c
Fig. 3 AvBD1 Variants and Membrane Permeabilisation: Calcein leakage
from liposomes incubated with AvBD1 variant peptides 0.3uM (a) and
0.5uM (b) for up to 1 min, and 0.5uM up to 3 min (c). Experiments
(N = 3;n = 3:mean ± SEM) performed at room temperature in 50 mM
sodium phosphate buffer. *p < 0.05; ***p < 0.001
Fig. 4 CD spectra of AvBD1 variant peptides. Peptides 250 μg/ml were analysed in 50 mM sodium phosphate buffer and following exposure to 1% SDS
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Lactobacilli sp. data suggested trends at Days 4 (9% LX
vs × 30% LY; P = 0.394) and 28 (20% LX vs 12%LY;
P = 0.323) respectively, no statistically significant
changes were detected. The emergence and colonisation
of the caeca with Barnsiella sp. were also evident in
both lines at Days 14 (9.5% LX vs 9.3%LY) and 28
(22% LX vs 26% LY), and the patterns were consistent
between the two lines. There were no significant
differences in the gut scores of the two lines although
the data suggested the LY birds to have healthier guts
overall (Fig. 6C & D).
Discussion
The earliest response of epithelia to microbial challenge
is mediated through the synthesis of innate immune fac-
tors and the defensins are key innate elements that
Fig. 5 Predicted secondary structures and simulated 3D structures of AvBD1 variants NYH (a/b), SSY (c/d) and NYY (e/f)
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function to protect the host from potential pathogens as
well as controlling the commensal microbial communi-
ties [25]. As genetic variation can potentially increase an
organism’s susceptibility to infection and disease, defen-
sin gene SNPs resulting in non-synonymous amino acid
changes are rare. Analyses of commercial chicken broiler
lines identified three lines carrying variants of the
AvBD1 gene encoding non-synonymous amino acid
changes at positions 10, 20 and 32 of the mature pep-
tide. The resulting peptides were designated as AvBD1
NYH, SSY and NYY, and comparison of their killing ac-
tivities indicated all to have antimicrobial properties
against gram negative and positive bacteria associated
with the chicken gut, but with a hierarchy of
NYH > SSY > NYY.
Cationic AMPs, including the defensins, are perceived
as targeting bacterial membranes through electrostatic
interactions and facilitating killing through permeation
of the intact membranes causing pore formation, and
leakage of the intracellular content [26, 27]. While it is
acknowledged that the in vitro AMA profiles of the
three AvBD1 peptides reflected their linear forms, this
scenario probably reflected the physiological situation in
vivo where the anaerobic environment of the gut, par-
ticularly the colon, favours the reduced form of the pep-
tide [15]. In vitro all three linear AvBD1 peptides
showed transition to an α-helical structure following ex-
posure to an anionic environment, which supported a
classical pore-killing mechanism in which the α-helix
lines up parallel to the membrane, inserts into the bi-
layer and disrupts membrane permeability, leading to
microbial cell death [28]. However, using CD analyses
the changes in peptide secondary structure between the
peptide variants were similar and hence could not ex-
plain the consistent observation that AvBD1 NYH pep-
tide was the most potent membrane permeabilising and
killing agent. Linear AMPs have been shown to function
directly through membrane pores [29], but the actual
mechanisms can differ with some peptides including lac-
toferricin (Lfcin B) associated with local rupture events
prior to pore formation [30]. Therefore in explaining the
observed hierarchy of the AvBD1 molecules it cannot be
excluded that the presence and positioning of the
AvBD1 NYH, NYY and SYY amino acids supported
novel rupture-like mechanisms.
Previous studies, focussed on ostrich defensins and
avian NK-lysin, linked membrane leakage properties and
hence microbial killing to peptide charge [11, 24]. This
association was not validated for AvBD1 as the net
charges of the three peptides were comparable. Similar
observations challenging the charge and killing potency
model were also reported for Apl_AvBD2 and AvBD8,
where the substitution of residues that impacted on pep-
tide charge (F/R and I/R) did not improve antimicrobial
activity [31, 32]. Moreover, the in vitro modelling of a
SNP encoding a non-synonymous R/I substitution iden-
tified in the Great Tit AvBD7 gene, indicated that only
the isoleucine allelic form associated with the lower
charged peptide (+3.7 v + 4.7), was associated with the
inhibition of Staphylococci growth [33]. So while cationic
charge is important for peptide killing other factors yet
to be determined appear to be involved in the AvBD1
mode of action. For example it could not be excluded
that the presence of H32 increased the antimicrobial
capacity of the AvBD1 NYH variant through localised
charge effects.
Modelling of the AvBD1 molecules indicated their na-
tive folded structures to be comparable, with each dis-
playing a three-stranded antiparallel β-sheet structure.
In contrast to AvBD2 [34], they were all predicted a
short N-terminal helical segment, the importance of
which in bacterial killing, was supported by the CD
spectra data. All three molecules were projected to dis-
play externalisation of positively charged and hydropho-
bic residues with the localisation of positively charged
amino acids R30, K27, R2 and K3, lending support to a
strong electrostatic interaction of the defensin molecules
with anionic bacterial membranes. Additionally F15, F31
and F7 provided interfacial hydrophobicity, with phenyl-
alanine residues shown previously by NMR to play key
roles in the binding of a cationic peptides to a negatively
charged membrane [35]. Structural modelling also iden-
tified distinct claw-like regions, which have been sug-
gested previously to play a key role in microbial
membrane attachment [32]. The claw regions were more
distinct in the NYH model and it is feasible in vivo that
such structures are involved and key factors in its mem-
brane attachment and permeating abilities.
Bioinformatics analyses of the AvBDs highlighted a
number of positively selected sites that would mutate at
a higher rate than expected [36, 37]. For AvBD1 these
corresponded to SNP2 (Y/S) and SNP3 (Y/H), and the
data presented herein supports these predictions. More-
over, while indicating a definite hierarchy, these data also
(See figure on previous page.)
Fig. 6 AvBD1 IHC and caecal microbiota analyses of LX and LY birds. IHC analyses to show epithelial localisation of AvBD1 in caecal tissues of
Day 4 LX birds using AvBD1 polyclonal antibody diluted 1:250 and peroxidase staining (×400 magnification) (a). Caecal microbiota profiles of LX
(b) and LY (c) birds (two independent trials using two different hatches) presented as relative abundance of bacterial genus (% microbial
population). Corresponding total gut health scores/sampled group at each time point is shown above each column. (d) individual gut health
data focussing on redness, watery digesta and gut tone where 0 (normal), 1 (some abnormalities) or 2 (very abnormal), and poorest guts scoring 6
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suggested that the amino acids encoded by the SNPS are
not detrimental to peptide killing and hence mucosal
host immunity, which probably explains their selection,
tolerance and conservation within the broiler chicken
lines. Gut performance is unlikely to rely on or reflect
the activity of a single gut antimicrobial peptide, but it is
known that caecal AvBD1 expression is maximal imme-
diately post hatch and maintained up to day 7 [13],
hence the increased potency of NYH variant could im-
pact on the composition of the caecal gut microbiota.
Lactobacilli sp. have been reported to be important for
immune development of the gut [38], with abundant
Lactobacilli numbers linked to a robust bird gut immune
system [39]. In vitro, the NYH peptide proved the most
potent form against L. johnsonii, a recognised gut pro-
biotic [40]. This raised the possibility that its synthesis
by the young LX birds could impact their gut health
through reduced colonisation with Lactobacilli, and ex-
posure of the gut epithelia to other potentially less pro-
tective bacterial species. While the caecal microbiota
data suggested the reduced abundance of Lactobacilli in
the microbiota of the Day 4 LX compared to LY birds,
these data were not statistically significant and hence did
not support the peptide as playing a role in gut health.
The observations supporting the in vivo synthesis of
three AvBD1 peptides with different antimicrobial activ-
ities appear to conflict with the chicken NK-lysin protein
where the most potent antimicrobial form is favoured
genetically [12]. However, unlike the defensins that are
synthesised by epithelial cells and heterophils [41],
NK-lysin molecules are synthesised and stored in the
cytotoxic granules of T lymphocytes, and Natural
Killer cells. Their release is part of a cell-mediated
immune response that has evolved and functions to
destroy microbes, particularly those surviving intracel-
lularly. Hence the necessity for intracellular pathogen
killing has presumably driven the selection of the
most potent NK-lysin agent.
Conclusions
This study identified three non-synonymous SNPs in the
AvBD1 gene encoding the variant peptides NYH, SSY
and S/NYY that segregated into three lines of commer-
cial broiler chickens LX, LY and LZ. While the peptide
antimicrobial hierarchy was determined in vitro as
NYH > SSY > NYY these changes did not appear to im-
pact on bird gut microbiota or health. However, these
data highlight the need for breeders to consider the im-
pact of host defence molecules on the commensal as
well as pathogenic populations in young birds as simply
selecting for the most potent version of genes encoding
peptides playing roles in innate immunity may not be
beneficial commercially.
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